Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Journal of the Egyptian Public Health Association [The]. 2008; 83 (5, 6): 435-450
in English | IMEMR | ID: emr-88330

ABSTRACT

This study was conducted to evaluate different regimens of 0.12% chlohexidine [CHX] rinse on the salivary parameters and Mutans Streptococci [MS] for a group of Egyptians. Twenty one females were recruited based on inclusive exclusive criteria. They were assigned to three different groups according to the CHX regimen specified. Salivary parameters [unstimulated salivary flow rate, stimulated salivary flow rate, pH and buffering capacity] and salivary mutans streptococci were evaluated at base line for all participants. Diet recording was done for 4 days in a supplied chart. DMFS and DS scores were also determined. This was followed by the use of 0.12% CHX mouth rinse once daily for 60 seconds before bedtime for either 3, 7 or 14 days. Salivary parameters were re-evaluated in the early morning after the use of the mouth rinse, after 1 month and 3 months. Mutans Streptococci [MS] were also evaluated at the same intervals. The salivary parameters did not show any difference throughout the study. The majority of the participants belonged to the moderate low fermentable CHO diet content category and they consumed five meals of cariogenic intake per day. Their DMFS scores ranged between 2 and 50 whereas the DS scores ranged between 2 and 10. The 3 day regimen was not statistically significantly different from the 7 and 14 days regimens and the maximum efficacy of CHX was obtained immediately after its use and lasted throughout the first week after stopping it. The effect of the CHX disappeared after 1 month and gradually reached the base line and surpassed this level sometimes. A regimen of once daily use of 15 ml of 0.12% CHX mouth rinse for 3 days is effective in reducing MS below critical values. It is recommended to reuse the CHX rinse after 1 month owing to the cessation of its effect. Patients who start using CHX should not discontinue it


Subject(s)
Humans , Female , Dental Caries/therapy , Anti-Infective Agents, Local , Saliva/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL